Home > Healthcare > Healthcare IT > Artificial Intelligence > Artificial Intelligence in Healthcare Market

Artificial Intelligence in Healthcare Market Share

Report ID: GMI1557
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Artificial Intelligence in Healthcare Market Share

The competitive landscape of the artificial intelligence in healthcare industry is characterized by the presence of established pharmaceutical & healthcare IT companies that manufacture AI-based healthcare products vying for market share. Key players are engaging in strategic initiatives such as collaboration, service launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for artificial intelligence in healthcare.

Artificial Intelligence in Healthcare Market Companies

Prominent players operating in the artificial intelligence in healthcare industry are as mentioned below:

Aidoc
AiCure
APIXIO, Inc.
Atomwise, Inc.
Butterfly Network
Dassault Systemes (Medidata)
Enlitic Inc.
Koninklijke Philips N.V.
IBM Corporation
iCarbonX
Insilico Medicine Inc
Itrex Group
IQVIA
NVIDIA Corporation
Sophia Genetics

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Artificial intelligence in healthcare industry size was worth USD 14.4 billion in 2023 and is projected to expand at 39.2% CAGR from 2024 to 2032, due to the advancement in AI techniques such as machine learning and deep learning, allowing for more accurate diagnostics, predictive analytics, and drug discovery.

The software offering segment in the AI in healthcare industry accounted for USD 11.7 billion in 2023, owing to the critical role of AI software in enhancing medical imaging analysis, aiding in early disease detection and accurate diagnostics through techniques like computer vision and pattern recognition.

The drug discovery segment accumulated 28.1% of the artificial intelligence in healthcare market share in 2023, as AI streamlines drug discovery process by reducing the time and cost associated with bringing new drugs to market.

North America artificial intelligence in healthcare industry accounted for 46.2% market share in 2023, led by the increasing need to reduce fraud and enhance data security in healthcare sector.